6-K

AURINIA PHARMACEUTICALS INC. 6-K

Company: Aurinia Pharmaceuticals Inc.
Filed: October 20, 2017
Period of Report: October 20, 2017
Accession Number: 0001157523-17-002726

View Document ↗ View on SEC.gov ↗